Bach, M. A., Rockwood, K., Zetterberg, C., Thamsborg, G., Hebert, R., Devogelaer, J. P.
, Christiansen, J. S., Rizzoli, R., Ochsner, J. L., Beisaw, N., Gluck, O., Yu, L., Schwab, T., Farrington, J., Taylor, A. M., Ng, J. & Fuh, V. (2004).
MK 0677 Hip Fracture Study Group. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
J. Am. Geriatr. Soc.,
52(4), 516-523.
Cingel-Ristic, V., van Neck, J. W.
, Frystyk, J., Drop, S. L. S. & Flyvbjerg, A. (2004).
hIGFBP-1 increases serum growth hormone in mice.
Endokrinologiya,
145, 4401-4407.
Clausen, L. R., Kristiansen, M. T., Rasmussen, L. M., Billestrup, N., Blaabjerg, O., Ledet, T.
& Jørgensen, J. O. L. (2004).
Growth hormone receptor expression and function in pituitary adenomas.
Clinical Endocrinology,
60, 576-583.
Degn, K. B., Brock, B., Juhl, C. B.
, Djurhuus, C. B., Grubert, J., Kim, D., Han, J., Taylor, K., Fineman, M. & Schmitz, O. (2004).
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycaemia.
Diabetes,
53, 2397-2403.